ALZHEIMER
ALZHEIMER’S DRUG TURNS BACK CLOCK IN POWERHOUSE OF CELL
Researchers have developed a new drug that can help treat Alzheimer’s disease and has been shown to reverse aging in mice.… READ MORE…
HOW ALZHEIMER’S SPREADS THROUGH THE BRAIN
Researchers investigate how toxic proteins associated with Alzheimer’s disease spread throughout the brain.… READ MORE…
MASSAGING BRAIN CELLS TO FIGHT ALZHEIMER’S
Researchers use tiny magnets to stretch small batches of individual neurons, helping to form new neural networks. … READ MORE…
GENETIC FACTORS THAT CONTRIBUTE TO ALZHEIMER’S IDENTIFIED
Boston University School of Medicine researchers have identified several new genes associated with Alzheimer’s disease, including some which may cause functional and structural alterations in the brain. The findings could help to shed light on the processes leading up to the development of the neurodegenerative disease.… READ MORE…
DIABETES DRUG ‘SIGNIFICANTLY REVERSES MEMORY LOSS’ IN ALZHEIMER’S: MOUSE STUDY
Lancaster University researchers report a drug developed to treat diabetes shows promise in reversing memory loss associated with Alzheimer’s in mouse models of the disease. The drug appears to have a neuroprotective effect, enhancing brain growth factors while reducing amyloid plaques, chronic inflammation and oxidative stress. The drug also slows down the rate of neuron loss.… READ MORE…
LACK OF SLEEP BOOSTS LEVELS OF ALZHEIMER’S PROTEIN
WUSTL researchers report a poor night’s sleep can cause levels of amyloid beta to rise faster than the brain’s waste disposal system can remove it. Researchers note frequent sleep disruptions can lead to an increased risk of developing Alzheimer’s disease.… READ MORE…
INFLAMMATION DRIVES PROGRESSION OF ALZHEIMER’S
Researchers report an inflammatory mechanism within the brain’s immune system may drive the progression of Alzheimer’s disease.… READ MORE…
A NON-INVASIVE METHOD TO DETECT ALZHEIMER’S
Researchers report an MRI test to measure smaller volumes in specific hippocampal regions could be used to detect Alzheimer’s disease.… READ MORE…
GENETICS STUDY ADDS FURTHER EVIDENCE THAT EDUCATION REDUCES ALZHEIMER’S RISK
A new study adds further weight to the theory that being educated may help to stave off Alzheimer’s disease.… READ MORE…
POPULATION OF AMERICANS WITH ALZHEIMER’S WILL MORE THAN DOUBLE BY 2060
Researchers predict by 2060 around 15 million Americans will be living with MCI or Alzheimer’s disease. Currently, 6.08 million people are living with dementia. … READ MORE…
CANOLA OIL LINKED TO WORSENED MEMORY AND LEARNING ABILITY IN ALZHEIMER’S
Temple University researchers report canola oil may have harmful effects on brain health. In a mouse model of Alzheimer’s disease, researchers discovered those exposed to canola oil in their diet had worsened memory and learning abilities. … READ MORE…
HEALTHY MITOCHONDRIA COULD STOP ALZHEIMER’S
Boosting mitochondria may defend against a form of protein stress that can reduce the formation of amyloid plaques, EPFL researchers report.… READ MORE…
ALZHEIMER
ALZHEIMER’S DAMAGE REDUCED WITH COMPOUND THAT TARGETS APOE GENE: MOUSE STUDY
Researchers from WUSTL have identified a compound that targets APOE in mouse brains and which protects against Alzheimer’s disease. The APOE4 genetic variant increases the risk of people developing Alzheimer’s disease. The findings offer new possible avenues of treating the disease in humans.… READ MORE…
LITHIUM IN WATER ASSOCIATED WITH SLOWER RATE OF ALZHEIMER’S DEATHS
A new study reports trace amounts of lithium in drinking water may slow death rates in people with Alzheimer’s disease. Researchers also discovered rates of obesity and diabetes are also lower in areas where lithium is present in the water supply. … READ MORE…
HYPERBARIC OXYGEN THERAPY MAY ALLEVIATE ALZHEIMER’S SYMPTOMS
Researchers report hyperbaric oxygen therapy could prove to be beneficial in the treatment of Alzheimer’s disease. According to a new study, HBOT may improve Alzheimer’s pathology and reduce some of the behavioral symptoms associated with the disease.… READ MORE…
NEW ALZHEIMER’S MODEL MORE CLOSELY MIMICS HUMAN DISEASE
A new mouse model of Alzheimer’s more closely resembles the human version of the disease. Researchers believe the new model may help accelerate new therapeutic avenues to treat the disease.… READ MORE…
GENE VARIANT THAT PROTECTS AGAINST ALZHEIMER’S IDENTIFIED
Researchers report people with a genetic predisposition to Alzheimer’s and who carry a variant in the RAB10 gene, may be more resilient to the disease than those without the genetic variant.… READ MORE…
IMAGING TECHNIQUE SHOWS PROGRESS OF ALZHEIMER’S AT CELL LEVEL AND BELOW
Using Raman imaging technology, University of Twente researchers have been able to obtain clear images of brain tissue affected by Alzheimer’s disease.… READ MORE…
NEW DETAILS ON AGED BRAIN, ALZHEIMER’S AND DEMENTIA
A new study that analyzed the brains of 107 older people sheds light on the neurobiology of both healthy and diseases aging.… READ MORE…
BENZODIAZEPINES INCREASE MORTALITY IN PERSONS WITH ALZHEIMER’S DISEASE
Researchers report an elevated risk of death in Alzheimer’s patients who use benzodiazapines.… READ MORE…
RESEARCHERS DESCRIBE A NEW BIOLOGY OF ALZHEIMER’S DISEASE
Researchers present a new model for the biology of Alzheimer’s disease in a Nature Neuroscience study. They note the findings could help lead to a new approach to treating the neurodegenerative disease.… READ MORE…
ASTROCYTES LINKED TO ALZHEIMER’S DISEASE
Researchers have discovered a direct association between astrocytes and Alzheimer’s disease. In a new study, researchers report astrocytes in the brains of Alzheimer’s patients produced significantly more amyloid beta than astrocytes in the brains of people without the disease.… READ MORE…
NANOWIRED DRUGS COULD TREAT ALZHEIMER’S AND PARKINSON’S PATIENTS
Using titanate nanowires treated with cerebrolysin, researchers have been able to target delivery to the brain and through the central nervous system. Researchers report the use of nanowires to deliver drugs could be beneficial in the treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases.… READ MORE…
DRUG COULD DERAIL SYNAPSE LOSS IN ALZHEIMER’S
Researchers report a drug called fasudil may help to prevent synapse loss initiated by amyloid beta peptides in early stages of Alzheimer’s disease.… READ MORE…
ALZHEIMER
SMELL TEST CHALLENGE SUGGESTS CLINICAL BENEFIT FOR SOME BEFORE DEVELOPMENT OF ALZHEIMER’S
Columbia researchers have identified a way in which to determine if a patient with MCI may respond to cholinesterase inhibitors.… READ MORE…
BIOMARKER MAY PREDICT EARLY ALZHEIMER’S
Researchers discover the DAG peptide can recognize specific protein elevation in brain blood vessels of both mouse models and humans with Alzheimer’s disease.… READ MORE…
SLEEP APNEA MAY INCREASE ALZHEIMER’S RISK
A new study reports on a surprising link between Sleep Apnea and Alzheimer’s disease. Researchers report people who suffer a number of apneas per hour have increased accumulation of amyloid beta in the brain over time.… READ MORE…
HOW SORLA PROTECTS AGAINST ALZHEIMER’S
A brain protein genetically lined to Alzheimer’s appears to limit the ability of amyloid beta to trigger synaptic dysfunction, a new study reports.… READ MORE…
HIGHER BRAIN GLUCOSE LEVELS MAY MEAN MORE SEVERE ALZHEIMER’S
A new NIH study reveals abnormalities in brain glucose metabolism could be linked to the severity of Alzheimer’s pathology.… READ MORE…
SAVING NEURONS MAY OFFER NEW APPROACH FOR TREATING ALZHEIMER’S DISEASE
According to researchers, the compound P7C3 may help to protect against neuron death and memory problems associated with Alzheimer’s disease without altering the buildup of amyloid plaques or neurofibrillary tangles in rat brains.… READ MORE…
CLINICAL TRIAL FINDS BLOOD-PLASMA INFUSIONS FOR ALZHEIMER’S SAFE AND PROMISING
A small group of people with Alzheimer’s who received an experimental blood plasma infusion from young donors showed some improvements in their condition, researchers report.… READ MORE…
EXPERIMENTAL BRAIN TECHNOLOGY CAN REWIND ALZHEIMER’S DISEASE
Researchers report repetitive transcranial magnetic stimulation can help to reverse some of the signs of Alzheimer’s disease. So long as patients receive the treatments, cognitive decline appears to halt and, in some cases, cognitive abilities improve.… READ MORE…
HERE’S WHAT WE THINK ALZHEIMER’S DOES TO THE BRAIN
A new paper explores different findings about the development of Alzheimer’s and considers how personalized treatments may help combat this complex disease.… READ MORE…
CORTICE BIOSCIENCES ANNOUNCES PRESENTATION OF RESULTS FROM PLACEBO-CONTROLLED PHASE 1 CLINICAL TRIALS EVALUATING TPI 287 FOR TREATMENT OF ALZHEIMER’S DISEASE AND RELATED TAUOPATHIES
Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).… READ MORE…
RESEARCHERS DISCOVER WHERE EARLIEST SIGNS OF ALZHEIMER’S OCCUR IN THE BRAIN
Researchers report they have discovered where the earliest signs of Alzheimer’s may occur in the brain. Initial accumulation of Alzheimer’s associated amyloid beta was discovered in an important functional network, the default mode network.… READ MORE…
ALZHEIMER’S DISEASE MIGHT BE A ‘WHOLE BODY’ PROBLEM
Using a technique called parabiosis on pairs of mice, researchers discover what they call ‘cancer like mobility’ of amyloid beta, reporting it can travel to the brain from other parts of the body.… READ MORE…